Artificial Blood Market

Artificial Blood Market - Size, Share, Growth,
Outlook, and Opportunity Analysis, 2018-2026
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have
been trying to develop artificial blood from various sources and through different methods to address
the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of bloodtype rejection have encouraged researchers to develop artificial blood, thus reducing the dependency
on blood donors.
Request Sample Copy of Research Report:
Transfusion of red blood cells (RBCs) is a standard and indispensable therapy for anemic conditions.
Blood transfusion process has progressed through various developments, including development of
acid-citrate-dextrose blood preservation solution, and cloning of ABO gene. However, blood
transfusion come with a high risk of infections. Recombinant erythropoietin stimulating agent therapy
has been the prominent therapy in cases such as chronic kidney disease, and chronic anemic
conditions. Yet in thrombotic and neoplastic complications, blood transfusion is the only option.
Hence, RBC production from hematopoietic stem cells has been the focus of regenerative therapy,
with major players investing billions of dollars in R&D related to this technique. However, the final
product is yet to receive U.S. Food & Drug Administration (FDA) approval.
Artificial Blood Market Development
There has been significant progress made in the global artificial blood market with respect to
finding a suitable method to produce blood cells. Scientists have been trying to develop artificial
blood from diverse molecules ranging from perfluorocarbons to hemoglobin. With the advent of
research in stem cells, researchers began to develop RBCs from stem cells of cord blood. The
enrollment for the first clinical trials of stem-cell based red blood cells began in 2009. This study
used stem cells from cord blood and adult bone marrow. The study was conducted at the
Hematological Laboratory at the University of Paris VI.
A similar research conducted by scientists at the University of Bristol and the UK’s National
Health Service (NHS) using stem cells from adult and umbilical cord blood has shown successful
results from initial studies. The study is scheduled to enter clinical trials with 20 subjects in 2017.
The focus of these trials is to provide special treatment for specific patient groups, rather than
act as complete replacement for blood.
Report includes chapters which deeply display the following deliverable about industry :
• Artificial Blood Market Research Objective and Assumption
• Artificial Blood Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Artificial Blood Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Artificial Blood Market, By Regions
• Artificial Blood Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Artificial Blood Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Artificial Blood Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Artificial Blood Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Key players in the artificial blood market are focused on research and development
activities to expand their product portfolio. For instance, in May 2019, Baxter
International announced new research on 3-in-1 Oxiris filter Set for continuous renal
replacement therapy (CRRT) and sepsis management. The filter removes cytokines
and endotoxins from the blood.
Inquire Here Before Purchase:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]